Xu Q - Search Results

1

Targeting Nutrient Dependency in Cancer Treatment.

Fan K, Liu Z, Gao M, Tu K, Xu Q, Zhang Y. Fan K, et al. Among authors: xu q. Front Oncol. 2022 Feb 1;12:820173. doi: 10.3389/fonc.2022.820173. eCollection 2022. Front Oncol. 2022. PMID: 35178349 Free PMC article. Review.

2

Evaluation of glioma-associated oncogene 1 expression and its correlation with the expression of sonic hedgehog, E-cadherin and S100a4 in human hepatocellular carcinoma.

Zheng X, Yao Y, Xu Q, Tu K, Liu Q. Zheng X, et al. Among authors: xu q. Mol Med Rep. 2010 Nov-Dec;3(6):965-70. doi: 10.3892/mmr.2010.375. Epub 2010 Sep 27. Mol Med Rep. 2010. PMID: 21472341

3

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.

Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K. Xu Q, et al. Mol Cancer. 2017 Jun 12;16(1):103. doi: 10.1186/s12943-017-0675-y. Mol Cancer. 2017. PMID: 28606154 Free PMC article.

4

HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.

Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K. Xu Q, et al. Mol Cancer. 2017 Dec 20;16(1):178. doi: 10.1186/s12943-017-0748-y. Mol Cancer. 2017. PMID: 29262861 Free PMC article.

5

MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.

Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L, Xu Q, Yang W, Liu Q, Tu K. Liu Z, et al. Among authors: xu q. J Exp Clin Cancer Res. 2018 Mar 6;37(1):49. doi: 10.1186/s13046-018-0717-3. J Exp Clin Cancer Res. 2018. Retraction in: J Exp Clin Cancer Res. 2022 Sep 13;41(1):272. doi: 10.1186/s13046-022-02487-y PMID: 29510736 Free PMC article. Retracted.

6

MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.

Xu Q, Zhu Q, Zhou Z, Wang Y, Liu X, Yin G, Tong X, Tu K. Xu Q, et al. Biomed Pharmacother. 2018 Jul;103:645-652. doi: 10.1016/j.biopha.2018.04.037. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29679906

7

Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca²⁺/PI3K/AKT pathway.

Dou C, Zhou Z, Xu Q, Liu Z, Zeng Y, Wang Y, Li Q, Wang L, Yang W, Liu Q, Tu K. Dou C, et al. Among authors: xu q. Oncogene. 2019 Feb;38(8):1239-1255. doi: 10.1038/s41388-018-0505-8. Epub 2018 Sep 24. Oncogene. 2019. PMID: 30250300

8

SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production.

Dou C, Xu Q, Liu J, Wang Y, Zhou Z, Yao W, Jiang K, Cheng J, Zhang C, Tu K. Dou C, et al. Among authors: xu q. J Exp Clin Cancer Res. 2019 Feb 12;38(1):70. doi: 10.1186/s13046-019-1067-5. J Exp Clin Cancer Res. 2019. PMID: 30755243 Free PMC article.

9

A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.

Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K. Wang Y, et al. Among authors: xu q. Mol Cancer. 2019 Feb 19;18(1):28. doi: 10.1186/s12943-019-0957-7. Mol Cancer. 2019. PMID: 30782188 Free PMC article.

10

miR-4666-3p and miR-329 Synergistically Suppress the Stemness of Colorectal Cancer Cells via Targeting TGF-β/Smad Pathway.

Ye J, Lei J, Fang Q, Shen Y, Xia W, Hu X, Xu Q, Yuan H, Huang J, Ni C. Ye J, et al. Among authors: xu q. Front Oncol. 2019 Nov 19;9:1251. doi: 10.3389/fonc.2019.01251. eCollection 2019. Front Oncol. 2019. PMID: 31824844 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,246 results

Search Page

Filters